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Abstract
Background: Patient portals are considered valuable instruments for self-management of long term conditions,
however, there are concerns over how patients might interpret and act on the clinical information they access.
We hypothesized that visual cues improve patients’ abilities to correctly interpret laboratory test results presented
through patient portals. We also assessed, by applying eye-tracking methods, the relationship between risk
interpretation and visual search behaviour.
Methods: We conducted a controlled study with 20 kidney transplant patients. Participants viewed three different
graphical presentations in each of low, medium, and high risk clinical scenarios composed of results for 28 laboratory
tests. After viewing each clinical scenario, patients were asked how they would have acted in real life if the results were
their own, as a proxy of their risk interpretation. They could choose between: 1) Calling their doctor immediately
(high interpreted risk); 2) Trying to arrange an appointment within the next 4 weeks (medium interpreted risk);
3) Waiting for the next appointment in 3 months (low interpreted risk). For each presentation, we assessed accuracy
of patients’ risk interpretation, and employed eye tracking to assess and compare visual search behaviour.
Results: Misinterpretation of risk was common, with 65% of participants underestimating the need for action across
all presentations at least once. Participants found it particularly difficult to interpret medium risk clinical scenarios.
Participants who consistently understood when action was needed showed a higher visual search efficiency,
suggesting a better strategy to cope with information overload that helped them to focus on the laboratory tests
most relevant to their condition.
Conclusions: This study confirms patients’ difficulties in interpreting laboratories test results, with many patients
underestimating the need for action, even when abnormal values were highlighted or grouped together. Our
findings raise patient safety concerns and may limit the potential of patient portals to actively involve patients in their
own healthcare.
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Background
Patient portals are frequently assumed to motivate and
involve patients in their own health and care [1–6].
These systems allow patients to book appointments on-
line, view laboratory test results, or communicate with
their physicians. Currently, many patient portals are for
patients living with long-term conditions [7, 8], where
longitudinal follow-ups are complex, and where self-
management is a key component [9].
Patients mainly use patient portals to check their la-
boratory test results [10–14]. Yet, laboratory test results
are among the most difficult data for patients to
understand [15–18], and there are concerns about the
suitability of patient portals to support patients in this
task [7, 19]. Misinterpretation of laboratory test results
can have adverse effects on patient safety, increase patient
anxiety, and reduce self-management efficacy [7, 14, 20].
With the increasing availability of patient portals [21, 22],
it is therefore important to understand how patients inter-
act with, and process, laboratory test results to inform the
online presentation of this information for accurate risk
interpretation and improved user interaction.
It is known that several contextual factors, like a pa-
tient’s numeracy and health literacy, can influence risk
interpretation in the context of online laboratory test re-
sults [17, 23], however little is known about the effect of
presentation on risk interpretation and interaction with
this type of information. Previous studies have reported
that patients found it difficult to understand laboratory
test results shown in tables [15–17, 23] and graphs
[15, 18], even when patients were familiar with the clin-
ical scenarios at hand (i.e. glucose level monitoring for
diabetes patients) [17]. A possible explanation for this
phenomenon is the way numerical data were presented to
patients [24]. Horizontal coloured bars that contextualise
the latest value in relation to the standard range have been
one of the few alternative presentations that have been im-
plemented to improve risk interpretation of laboratory test
results [16, 23]. They outperformed tables in terms of per-
ceived usefulness [16] and decrease perceived urgency of
borderline (i.e. low deviance from reference range) labora-
tory test results [23]. However, so far they have been only
tested on static implementations (e.g., not on fully func-
tioning patient portals) and on a limited number of la-
boratory tests at the same time. More widely, there are
new presentation techniques that have been shown to en-
hance human decision making and information seeking
behaviours in other web-based contexts [25–30]. How-
ever, these have not been tried in patient portals. For ex-
ample, grouping (e.g., presenting together items that have
similar characteristics) combined with the overview pre-
view metaphor (e.g. where all user interaction happens
within the same page) have been proven more effective
than tables or list-based presentations in information-
seeking and decision-making tasks [28–30]. However, this
approach was never tested in the context of online labora-
tory test results.
We conducted a controlled study in which participants
accessed different web-based presentations of laboratory
test results across different clinical scenarios. We hypothe-
sized that presentations using colour, which positively in-
fluences human cognition for risk interpretation tasks
[31], and graphical cues (e.g., horizontal coloured bars and
personalised grouping) improve patients’ interpretation of
laboratory test results presented through patient portals.
To investigate whether correct interpretations were asso-
ciated with specific visual search behaviours, our second-
ary objective was to assess and compare metrics derived




We focused on patients with Chronic Kidney Disease
(CKD), for whom there is an online platform, named
PatientView [32], that provides access to laboratory
results and is available in 90% of renal units in the UK.
We included patients who had a kidney transplant (at
least 12 months before recruitment). These patients
undergo longitudinal follow-up with quarterly visits,
including a review of their laboratory test results. This
allowed us to obtain a homogeneous group of partici-
pants in terms of their experience with and knowledge
of the disease. We excluded patients with any visual im-
pairment, to avoid ineffective eye tracking data collec-
tion, and patients who did not use the internet in their
everyday lives, to ensure a certain level of digital profi-
ciency required to be a potential patient portal user.
We recruited 20 patients from the Renal Transplant
Clinic at Salford Royal NHS Foundation Trust (SRFT),
which has one of the largest communities of PatientView
users in the UK. The study received ethical approval from
NHS and local R&D ethical committees (IRAS ID: 183,845).
Research nurses from the NIHR Clinical Research
Network Portfolio (Study CPMS ID: 20,645) were respon-
sible for approaching eligible patients and collecting signed
informed consents of patients willing to participate.
Patient involvement
Increasingly patients are becoming involved as active
partners in planning and undertaking research, rather
than only as participants or data sources [33]. Through-
out the project, we involved three patients from the local
CKD patient community (http://gmkin.org.uk/) as col-
laborators, of whom two had experience of using
PatientView. Initially, these patient collaborators partici-
pated in a workshop with researchers, during which they
provided insights on their perceived importance and
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relevance of monitoring laboratory test results in CKD,
and the role of PatientView in such tasks. During the
workshop the patient collaborators also commented on
preliminary visual presentations that we had prepared
based on the literature discussed in the background and
suggested additional features that might support them in
interpreting their laboratory results on PatientView.
After the workshop the patient collaborators were in-
volved via email, providing comments on visual presen-
tations and the study protocol. One patient collaborator
also pilot-tested our data collection procedure and com-
mented on our interpretation of the results.
The continuous involvement of patient collaborators
allowed us to design a more realistic, relevant and ac-
ceptable experiment. Furthermore, two of our patient
collaborators were experienced PatientView users, often
interacting with other fellow patients in the local CKD
patient community on this topic. Therefore, their advice
and feedback was extremely important while developing
our visual presentations.
Controlled study design
The study followed a “3 × 3” repeated measures, within-
subjects design where each participant used, in a ran-
dom order, three different presentations of web-based
laboratory test results to complete the same simulated
task in three different clinical scenarios. These were
designed by a nephrologist at SRFT to reflect:
 High risk clinical scenarios: characterised as life
threatening situations that required immediate
action; creatinine and estimated Glomerular
Filtration Rate (eGFR) (i.e. the main indicators of
kidney function [34]), as well as potassium
(associated with higher mortality in kidney patients
[35]) strongly deviated from the standard range.
 Medium risk clinical scenarios: identified by
abnormal creatinine and eGFR, but normal
potassium and stable conditions; no urgent action
was necessary, however further tests were required
within 4 weeks;
 Low risk clinical scenarios: characterised by normal
creatinine, eGFR and potassium; not requiring any
action until the next scheduled appointment.
In addition to creatinine, eGFR and potassium each
scenario included 25 laboratory test results with differ-
ent deviances from the standard range in relation to the
reflected risk (i.e. higher risk scenarios had more con-
comitant abnormal values).
There was no previous training or time limit for per-
forming the task. Participants could decide to stop
exploring the laboratory test results whenever they felt
ready to reply to the follow up questions.
The controlled study was conducted at the Interaction
Analysis and Modelling laboratory of the University of
Manchester, and each patient participated individually. All
participants performed the tasks using a desktop com-
puter with a 17-in. screen with an embedded eye tracker
(Tobii T60), which permits a 60-Hz sampling rate, 0.5
degrees gaze point accuracy, and free head motion.
Presentations
We implemented three presentations of laboratory test
results (see Fig. 1 and Additional file 1: Figure S1-S9 for
details). In developing these presentations, we aimed at
maintaining similar amount of textual information, but
showing it through different formats and visual cues to
enhance patient interpretation. These were chosen based
on review of the literature and patient collaborators’
feedback on preliminary prototypes.
The Baseline presentation was based directly on, and
very similar to, the current PatientView [32] interface,
which uses tiles to show the latest available laboratory test
results. Each tile reports information on the value of a
laboratory test, its unit, the date of the test, data source,
and standard range. By clicking on a tile the user can
access previous results (i.e. longitudinal information), with
the possibility of comparing it with another test within the
same graph. This feature can be particularly useful in the
context of CKD, where the use of some medications im-
proves renal function but can also negatively affect the
functioning of other organs. This would be reflected by
abnormal values in laboratory test results.
The comparison presentations were based on the
Baseline presentation, but provided different visual cues,
colours and tools to show normal and abnormal values.
Chronic patients have an increased risk of having test re-
sults falling slightly outside the reference range, with
only those with high deviance from the population refer-
ence range likely to be clinically relevant [36]. Therefore,
the second presentation (Contextualised presentation)
used horizontal coloured bars that contextualise the lat-
est value in relation to the standard range in each tile
[16, 23, 37], which, as already said in the background,
have outperformed tables in terms of perceived useful-
ness [16] and decrease perceived urgency of borderline
(i.e. low deviance from reference range) laboratory test
results [23]. The third presentation (Grouped presentation)
aimed at helping patients in identifying abnormal results,
and made use of personalised grouping (i.e. dynamically
grouping the tiles in “Outside the standard range”, “No
standard range available”, and “Inside the standard range”)
and the aforementioned overview-preview metaphor
[28–30]. Both the Contextualised and Grouped presenta-
tion graphs reported personalised statistics for the selected
test [38–40] and used colours, showing the area inside the
standard range in green and the remaining area in red
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[41]. We applied the same approach to colour the latest
laboratory test results in the tiles in both presentations.
This had the aim of drawing patient’s attention on labora-
tory test results that might require more careful review
(i.e. the ones in red), as well as visually filtering out those
ones that were normal (i.e. the ones in green).
All plots within the same scenario displayed the same
time period to avoid the well-known difficulties with
scale changes [42]. Particularly, each plot displayed the
period from the earliest to the latest laboratory test re-
sult available, which for each scenarios was between 1
and 2 years. Furthermore, in order to make the task as
realistic as possible (i.e. pretending to have just received
some results from the clinic), all results were shifted to-
wards the day the experiment was carried out.
Since the purpose of the experiment was to expose pa-
tients to three very different types of scenario, keeping
fixed ranges for each laboratory test as suggested by
Zikmund-Fisher et al. [23] would have been detrimental
for our purpose. That is, predefined value ranges specific
to the type of clinical scenario (i.e. low, medium and
high risk) might have revealed the pattern shown in the
data. Therefore, we dynamically tailored the value ranges
shown in the plots, for all three presentations, and hori-
zontal coloured bars, for the Contextualised presenta-
tion. Specifically, the range of values shown always
included the minimum and maximum value of the
longitudinal series of results for each laboratory test. If
the minimum or maximum fell inside the laboratory test
reference range, they were replaced by lower and upper
reference range limit, respectively. To ensure that the
within and outside reference range areas were always
clearly displayed, an offset was added to the minimum
and maximum of the value range.
Data collection
At the beginning of the experiment each participant was
asked to complete four questionnaires: demographics
(age, gender, education, years since transplant, frequency
of internet usage, and frequency of PatientView use);
Subjective Numeracy Scale (SNC) [43] on a 1–6 scale;
self-reported health literacy on a 0–4 scale based on Chew
et al. [44], with lower scores indicating better health
literacy; and graph literacy, calculated as % of correct an-
swers on the questionnaire from Galesic et al. [45].
After exploring each presentation of laboratory test re-
sults, participants were asked to respond to a question
about their behavioural intentions in relation to what they
saw, which we used as a proxy of their risk interpretation.
Particularly, patients were asked what they would do in
real life if the results they had just explored were their
own. They could choose between: 1) Calling their doctor
immediately (high interpreted risk); 2) Trying to arrange
an appointment within the next 4 weeks (medium
Fig. 1 Latest test results overview and longitudinal detailed information for one or two tests at the same time across the three presentations.
Coloured rectangles represent the different areas of interest (AoIs) we defined across the three presentations (yellow: latest test results; blue:
single graph; purple: comparison graphs)
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interpreted risk); 3) Waiting for the next appointment in 3
months (low interpreted risk).
Data analysis
Risk interpretation
To assess the effect of the presentations (Baseline,
Contextualised and Grouped) on the accuracy of risk in-
terpretation, we created a 3 × 3 confusion matrix for
each presentation that reported the judgments made by
patients versus our gold standard (i.e. nephrologists’ clin-
ical judgement). From the confusion matrices, we calcu-
lated precision (i.e. proportion of correct interpretations
of all interpretations as risk X), recall (i.e. proportion of
correct interpretations on clinical scenarios with risk X)
and accuracy (i.e. proportion of correct interpretations
of all interpretations) for each presentation, and com-
pared these using chi-squared tests.
We repeated the analysis with a secondary definition
of the outcome, which aimed at investigating a situation
in which, from a safety perspective, a misjudgement
could have serious consequences. We evaluated the pre-
sentation’s performance in terms of patients correctly
identifying the need for action (i.e. at least medium
interpreted risk in medium and high risk clinical scenar-
ios). To evaluate whether performance was driven by
single patients (i.e. there were some patients that misin-
terpreted most of the information), we counted the mis-
takes that each patient made. We distinguished between:
patients underestimating the need for action (i.e. low
interpreted risk in medium or high risk scenarios); and
patients over-estimating the need for action and asking
for help when not needed (i.e. interpreted medium or
high risk in low risk clinical scenarios).
Visual search behaviour
To investigate whether correct interpretations were re-
lated to specific visual search behaviours, our secondary
objective was to evaluate differences (if any) in eye-
tracking data between patients who consistently identi-
fied the need for action and those who did not in at least
one occasion. We collected the following metrics:
 Fixation count: a fixation is a stable gaze on screen
lasting between 40 and 500 ms. We collected the
number of fixations lasting at least 180 ms [46],
because higher thresholds are considered to be more
reliable when the stimuli include graphical content
[47]. Fixation count is an indicator of visual search
efficiency [48].
 Average fixation duration: we computed the average
fixation duration, as an indicator of task difficulty
and cognitive load whereby longer fixation durations
indicate more challenging tasks [48].
 Dwell time: this metric, which is the aggregated
fixation duration, is typically an indicator of
attention and interest [48].
There were three AoIs in each presentation (see
Additional file 1: Figure S1): 1) tiles showing the latest
values for all laboratory tests; 2) the graph showing de-
tailed longitudinal information for a single laboratory
test; 3) the graphs comparing detailed longitudinal infor-
mation for two laboratory tests. At first sight, due to
their clear demarcations, the natural unit for defining
AoIs would have been each single tile. However, their
small size would have resulted in unreliable data because
the precision of the eye-tracker is compromised with
smaller AoIs. What is more, all the tiles convey the same
functionality so the added value of treating them inde-
pendently would have been negligible. Consequently we
defined larger AoIs that grouped widgets with the same
appearance and functionality.
Overall differences in fixation count and dwell time
were assessed with a mixed ANOVA, including patient
group (i.e. patients who did not underestimate the need
for action versus the others) and the within subject fac-
tors (i.e. presentation, clinical scenario and specific
AoIs). We also assessed differences in fixation durations
with a mixed ANOVA, this time not accounting for the
specific AoI in the within-subject factors. This choice
was mandated by the low frequency with which partici-
pants looked at some AoIs, therefore limiting our statis-
tical power in assessing differences. To account for the
skewedness and non-normality of residuals introduced
by count and bounded data, we ran the mixed ANOVAs
on the log-transformed eye fixation counts, eye fixation
duration, and dwell time, rather than on the raw data.
Eye-tracking data were extracted using the Tobii
Studio (version 3.4.0). All data analyses were performed
in R version 3.3.1 [49].
Results
Patient characteristics
Table 1 reports the characteristics of the 20 patients who
participated in the study. The majority were male, had at
least a college education and used the internet for more
than 5 h per week. Frequency of PatientView use was
balanced within our study population, with 11 partici-
pants who were regular users (i.e. quarterly use) and the
remaining nine using it less than twice per year.
Data analysis
Risk interpretation
Table 2 shows the confusion matrices and performance
measures (precision and recall) for all presentations
across the clinical scenarios (i.e. low, medium and high
risk). In most cases, patients correctly interpreted low
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and high risk clinical scenarios across all the presentations,
while medium risk clinical scenarios were often confused
with low risk ones. For each presentation, at least two pa-
tients misinterpreted high risk clinical scenarios as low risk
ones. The precision scores of the interpreted risks were
similar for the Baseline and Contextualised presentations,
and ranged from 0.33 to 0.69 and from 0.38 to 0.70, re-
spectively. For the Grouped presentation performance was
lower, and ranged between 0.28 and 0.58. Likewise, recall
scores for the Baseline and Contextualised presentations
were similar, and ranged from 0.30 to 0.70. The only main
difference was observed for high risk clinical scenarios,
where recall was 0.70 for the Contextualised presentation
and 0.55 for the Baseline. Again, a drop in performance
was noticed for the Grouped presentation. Overall accuracy
was 0.55 for the Contextualised presentation, 0.52 for the
Baseline presentation and 0.45 for the Grouped presenta-
tion. These differences were not statistically significant, with
all P-values in pairwise comparisons greater than 0.350.
In addition, we calculated confusion matrices to com-
pare situations in which an action was needed (i.e. sce-
narios with at least medium risk) versus those that did
not require any action (i.e. low risk clinical scenarios)
(see Table 3). For scenarios where an action was needed,
the three presentations performed similarly with a preci-
sion around 0.8 and a recall around 0.7. However, in
about 50% of the scenarios where patients interpreted
that no action was needed, this was not in line with the
gold standard. We did not find statistically significant
differences between the different presentations, with
P-values greater than 0.700 in pairwise comparisons.
Additional file 1: Table S1 shows the number of times
patients underestimated or overestimated the need for
action across all presentations and clinical scenarios.
Thirteen patients (65%) underestimated the need for ac-
tion at least once, of whom seven (35%) misinterpreted
at least half of the scenarios requiring an action. Four-
teen patients (70%) overestimated the need for action at
least once. Individual patient characteristics are reported
in Additional file 1: Table S2 and S3.
Visual search behaviour
We were not able to track eye movements for two par-
ticipants, resulting in 18 patients being included in the
Table 1 Patients’ characteristics
Parameters Values
Number of patients 20
Gender Female, n (%) 4 (20)
Male, n (%) 16 (80)
Age in years, mean (SD) 51.8 (10.3)
Years since kidney transplant, mean (SD) 10.7 (8.7)
Subjective Numeracy Scalea, mean (SD) 4 (0.8)
Health literacyb, mean (SD) 0.5 (0.6)
Graph literacyc score, mean (SD) 73.5 (11.3)
Education Lower than GCSE, n (%) 1 (5)
GCSE, n (%) 7 (35)




Internet use Less than one hour per week, n (%) 1 (5)
One to five hours per week, n (%) 5 (25)
Five to 10 h per week, n (%) 5 (25)
More than 10 h per week, n (%) 9 (45)
PatientView use Never used, n (%) 3 (15)
No more than once per year, n (%) 5 (25)
Twice per year, n (%) 1 (5)
Quarterly, n (%) 11 (55)
Abbreviations: SD Standard deviation, SNC Subjective Numeracy Scale,
GCSE General Certificate of Secondary Education
aOn a 1–6 scale [43]
bOn a 0–4 scale, with values close to 0 indicating better self-reported health
literacy [44]
cPercentage [45]
Table 2 Confusion matrix of the interpreted risk by patients versus the risk of clinical scenarios as assessed by nephrologists
(gold standard), and performance (i.e. precision and recall) for each presentation
Presentation Interpreted risk
by participants
Clinical scenarios (gold standard) Performance
Low risk Medium risk High risk Precision Recall
Baseline Low 14 10 2 0.54 0.70
Medium 5 6 7 0.33 0.30
High 1 4 11 0.69 0.55
Contextualised Low 13 9 2 0.54 0.65
Medium 6 6 4 0.38 0.30
High 1 5 14 0.70 0.70
Grouped Low 11 9 3 0.48 0.55
Medium 7 5 6 0.28 0.25
High 2 6 11 0.58 0.55
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eye tracking data analysis. Encountering difficult eye-
tracking circumstances in about 10% of participants is
not uncommon in eye tracking studies [50]. This can be
related to participant’s characteristics like glasses, par-
ticular shapes of eye-lids or very small pupils [50].
Overall, we observed 5071 eye fixations across all pa-
tients and clinical tasks on any of the three AoIs, with
an overall time of 1416 s (23.6 min) and a mean fixation
duration of 0.279 s (Standard Deviation [SD], 0.129 s).
The median total eye fixation count per patient across
the nine tasks was 255 (Inter Quartile Interval [IQI],
108–422), while the median total dwell time was 75 s
(IQI, 29–120 s).
Of the patients for whom we could track eye move-
ments, eleven underestimated the need for action at
least once, while seven consistently understood when an
action was needed. Figure 2 shows their eye fixation
counts across the different presentations, scenarios, and
AOIs, with medians ranging between 0 and 25 eye fixa-
tions. No statistically significant differences were found
among the different presentations in the mixed ANOVA
(P = 0.247), with median fixation count that was 22 (IQI,
6–46), 20 (IQI, 8–43), and 21 (IQI, 6–44) for the
Baseline, Contextualised and Grouped presentation, re-
spectively. Also no significant differences were found be-
tween the different clinical scenarios (P = 0.842), for
which we observed an overall median of 18 (IQI, 7–48)
fixations for low risk clinical scenarios, 23 (IQI, 6–39)
fixations for medium risk clinical scenarios, and 21 (IQI,
5–45) fixations for high risk clinical scenarios. Con-
versely, different patterns were found for the different
AoIs, with a P-value below 0.001 in the mixed ANOVA.
Particularly, patients mostly looked at the AoI contain-
ing the summary of the latest test results, with a median
of 13 fixations (IQI, 4–26) against 3 (IQI, 0–13) and 0
(IQI, 0–0) for the single graph and comparison graphs
AoIs respectively. The latter was mainly looked at in the
Grouped presentation. This was confirmed by the mixed
ANOVA test that found a statistically significant result
for the interaction term between presentation and the
specific AoI (P < 0.001). In terms of the main difference
between the two groups of patients, we found that patients
who never underestimated the need for action required
fewer eye fixations to make a decision, with overall median
fixation counts of 11 (IQI, 2–28) and 32 (IQI, 13–58). This
was shown also by the mixed ANOVA, where the term
referring to patient’s group was statistically significant
(P = 0.021). Similar results were found for dwell time
(see Additional file 1: Figure S10).
Eye fixation durations are shown in Fig. 3, with me-
dians between 0.202 and 0.313 s. We did not find differ-
ences in eye fixation durations between the different
presentations (P = 0.186), which had median fixation
duration values between 0.260 (IQI, 0.245–0.275) sec-
onds for the Contextualised presentation and 0.268 (IQI,
0.243–0.294) for the Baseline presentation. Also no dif-
ference was found across patient groups for the different
tasks (P = 0.357), with a median of 0.268 (IQI, 0.246–
0.287) seconds for patients who underestimated the need
for action and 0.259 (IQI, 0.218–0.303) seconds for
those who did not. The only statistically significant dif-
ference we found was between low, medium, and high
risk clinical scenarios (P = 0.028). Median values were
0.255 (IQI, 0.231–0.275), 0.272 (IQI, 0.246–0.298) and
0.266 (IQI, 0.246–0.289) seconds, respectively. This is
not surprising, as lower eye fixation durations reflect less
cognitive demand, which is expected for low risk clinical
scenarios. Although not statistically significant (P of
interaction term equal to 0.161), it is interesting to high-
light how the two groups of patients showed different
cognitive loads in relation to the risk presented. Particu-
larly, for low and high risk clinical scenarios, patients
who did not underestimate the risk had lower median
values across the three presentations. While the opposite
was observed for medium risk clinical scenarios.
Discussion
We conducted a controlled study to investigate whether
presentations using colours and graphical cues (e.g.,
horizontal coloured bars and personalised grouping) im-
prove patients’ abilities to correctly interpret laboratory
test results presented through patient portals.
Table 3 Confusion matrix of the interpreted risk by patients versus the gold standard (nephrologists judgement) and performance
(i.e. precision and recall) for clinical scenarios where an action was needed (i.e. at least medium risk) and those where no action was
needed (i.e. low risk)
Presentation Interpreted risk
by participants
Clinical scenarios (gold standard) Performance
Action needed No action needed Precision Recall
Baseline Action needed 28 6 0.82 0.70
No action needed 12 14 0.54 0.70
Contextualised Action needed 29 7 0.81 0.72
No action needed 11 13 0.54 0.65
Grouped Action needed 28 9 0.76 0.70
No action needed 12 11 0.48 0.55
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Fig. 3 Fixation duration (in seconds) across the three different clinical scenarios and three different presentations. Participants are stratified by
those who never underestimated the need for action (n = 7) and those who did (n = 11). To facilitate comprehension two measurements
pertaining to the 99th percentile (i.e. fixation durations greater than 0.400 s) were excluded from this graph
Fig. 2 Fixation count on the different areas of interest across the presentations and clinical scenarios for patients who never underestimated the
need for action (n = 7) and those who did (n = 11). To facilitate comprehension four measurements pertaining to the 99th percentile (i.e. fixation
count greater than 100) were excluded from this graph
Fraccaro et al. BMC Medical Informatics and Decision Making  (2018) 18:11 Page 8 of 12
We found no influence of presentation on the accur-
acy of risk interpretation, with misinterpretation of risk
being consistently high across the three presentations.
Notably, 65% of patients underestimated the need for ac-
tion at least once, and in 50% of the scenarios where pa-
tients decided not to act on the presented information it
would have been better to do so. This happened despite
the presentation of visual and graphical cues; grouping
of laboratory test results with normal and abnormal
readings; and personalised descriptive statistics. These
findings raise patient safety concerns and confirms that
the presentation of laboratory test results, in terms of
interface design alone, might not be enough to ensure
the accuracy of risk interpretation [19].
To the best of our knowledge this is the first study to
assess the effect of different presentations of laboratory
test results on risk interpretation by implementing pre-
sentations of different systems where patients could ex-
plore a broad panel of laboratory results and detailed
longitudinal information. Previous studies have exam-
ined how patients interpret risk in the context of labora-
tory test results [15–17, 23, 51]. While these studies also
found that patients had difficulties in interpreting risk
correctly, only two made comparisons between different
presentations of laboratory test results [16, 23]. Particu-
larly, Brewer et al. [16] and Zikmund-Fisher et al. [23]
compared a tabular format to horizontal coloured bars.
In line with our results, Brewer et al. [16] did not find
significant improvement in recall. Conversely, Zikmund-
Fisher et al. [23] found improvements in terms of under-
standing the level of urgency of near-normal laboratory
test results when using coloured bars instead of a tabular
format. They also found that high risk clinical scenarios
were perceived as urgent, independent of the type of
presentation used, which is consistent with our findings.
Their finding on near-normal results is difficult to com-
pare to our results as we did not test this clinical sce-
nario: conversely to our medium risk clinical scenarios,
their aim was to decrease the level of perceived urgency
rather than prompt an action.
As shown by the confusion matrix in Table 2, partici-
pants in our study found it more difficult to recognise
medium risk than low or high risk clinical scenarios. In
addition, as displayed by the eye tracking data, medium
risk clinical scenarios seemed to be more cognitively de-
manding even for those who never underestimated the
need for action. This is a unique finding of our study, as
most of previous studies that looked at patients’ inter-
pretation of laboratory test results limited the task to the
identification of abnormal values [15, 16, 52]. We used
an approach similar to Zikmund-Fisher et al. [17, 23]
who evaluated participants’ behavioural intentions in rela-
tion to interpretation of laboratory test results. The differ-
ence in our study was the explicit use of participant’s
behavioural intentions as a proxy of their interpreted risk.
This allowed us to reflect different clinical scenarios that
are likely to happen in real life, and evaluate patients’ in-
terpretation in a more naturalistic way.
This is the first study to adopt eye-tracking data in the
context of risk interpretation of laboratory test results in
patient portals. We found that patients who never
underestimated the need for action had less eye-fixation
counts and a shorter dwell time across the different pre-
sentations and clinical scenarios. This suggests a more
targeted visual search behaviour consistently adopted by
these patients, who were able to filter the data on-screen
and focus their attention on the relevant pieces of infor-
mation. These pieces of information are likely to be the
laboratory tests most relevant to their condition, helping
them to understand whether an action was needed. Con-
versely, patients who underestimated the need for action
distributed their attention over the different AoIs for
longer dwell time and more eye-fixation counts suggest-
ing difficulty in finding the right piece of information to
focus on. The importance of these results are twofold.
First, this confirms the importance of patient education
(i.e. teaching which laboratory tests are more important
and when they should act) prior to the use of patient
portals [53]. Second, from an interface design perspec-
tive, further highlighting the pieces of information that
are most relevant for patients and filtering those that are
less relevant might enhance patients’ interpretation.
Without making dramatic changes to the PatientView
interface we used for our study, this could be achieved
by taking advantage of reading patterns on the Web and
placing the most relevant information accordingly: atten-
tion decreases from left to right and from the top to the
bottom area of the screen following an F-shaped reading
pattern [54]. Therefore, placing relevant information
closer to the left-top corner would remove information
overload and facilitate decision-making. If the layout of
the user interface could be altered, the most relevant in-
formation could be allocated a larger area than the
remaining pieces of information shown (e.g. larger tiles
if we refer to the PatientView interface), as size of the
user interface elements has been proved to be one of the
main features to draw attention on Web pages [55].
Limitations
Our study has several limitations. First, since our objective
was to study risk interpretation and visual search behav-
iour in depth, each participant had to visit our eye-
tracking laboratory, requiring a substantial time and finan-
cial investment from the research team. Due to research
resource limitations, it was not possible to perform the
study with a larger cohort of patients. This limited our
statistical power to investigate the association between risk
interpretation and patient characteristics (i.e. health
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literacy, numeracy and graph literacy), which have previ-
ously been shown to be relevant in the context of labora-
tory test result interpretation [17, 23]. Furthermore,
although the population we selected was homogeneous in
terms of their experience with monitoring their laboratory
test results (i.e. all having quarterly tests after the kidney
transplant), the small sample size limits the generalisability
of our findings. However, our study still provides import-
ant insight on the risk interpretation and visual search be-
haviours of patients accessing laboratory test results on
patient portals, and it should be considered as comple-
mentary, rather than alternative, to other studies that had
larger populations, but studied risk interpretation in less
depth (e.g. using static prototypes or surveys). Second, pa-
tients were given fictitious clinical scenarios to assess risk,
in which they might have been less cautious because of
the simulation nature of the study. Observing patients’ in-
terpretation of data from their own laboratory test results
could simulate a more naturalistic research environment
and strengthen the applicability of our results in clinical
practice. Finally, since the study was performed in a la-
boratory setting where participants knew they were ob-
served and studied, participants’ behaviours might have
been different than their behaviours in real life as conse-
quence (i.e. Hawthorne effect).
Conclusions
This study confirmed patients’ difficulties in interpreting
laboratory test results, with many patients underestimat-
ing the need for action even when abnormal values were
highlighted using colours and graphical cues. Partici-
pants who consistently understood when action was
needed showed a higher visual search efficiency, suggest-
ing a better strategy to cope with information overload,
enabling them to focus on the laboratory tests most rele-
vant to their condition. Our findings raise concerns over
the limitations of patient portals in supporting self-care
and possible safety risks.
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